In this paper we aimed to assess: (1) the cross-sectional relationship between BMI and NTproBNP in the full spectrum of metabolic diseases mediated by insulin-resistance, overweight/obesity, metabolic syndrome and diabetes; 2) the effect of CVD on NTproBNP levels in these conditions. This evidence concerns the gene NPPB and obesity due to melanocortin 4 receptor deficiency.